Rhenium-186 NanoLiposomes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rhenium-186 NanoLiposomes, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment [Phase 1]